Published in Diabetes Week, March 1st, 2010
"A total of 546 patients were randomized and similar to 74% of patients completed the Study in each group. HbA(1c) values were slightly higher in the gliclazide group (HbA(1c) of 8.7 +/- 0.1 % vs. 8.5 +/- 0.1 % in the vildagliptin group). The mean...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.